- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05922475
Efficacy of Pre-sleep or Post-exercise Protein During 12 Weeks of Resistance Exercise Training
Neither Pre-sleep Nor Post-exercise Protein Consumption Influences Resistance Exercise Training Adaptations in Older Adults
The goal of this clinical trial is to compare the effects of protein consumption before sleep or immediately after exercise during 12 weeks of resistance exercise training in older adults. The main questions it aims to answer are:
Are there differences in muscle growth or strength during 12 weeks of resistance training when 40 grams of protein is consumed either before sleep or immediately after exercise? Are there differences in cognitive performance during 12 weeks of resistance training when 40 grams of protein is consumed either before sleep or immediately after exercise?
This study is a randomized double-blind placebo-controlled study. Participants will be randomly allocated into 1 of 3 groups. All three groups will perform the same 12-week resistance exercise training program two times per week and consume 40 g of protein: 1) Immediately post-exercise, 2) 30 minutes prior to sleep, or 3) no supplemental protein (control). Test of muscle growth and strength, and cognitive performance will be measure before, during, and after the exercise training program.
Researchers will compare the 3 conditions to determine if consume protein after exercise or before sleep during 12 weeks of resistance exercise training affects muscle growth and strength, and cognitive performance.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Florida
-
Tallahassee, Florida, United States, 32306
- Florida State University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Male between 60-75 years old at the time of enrollment.
Exclusion Criteria:
- Diagnosis of cardiac or peripheral vascular disease
- Stroke, kidney dysfunction
- Metabolic disease
- Uncontrolled hypertension
- Orthopedic limitations
- Skeletal muscle complications
- Milk allergy
- Psychiatric conditions
- Use of psychotropic drugs
- Cognitive impairment (scoring 26 points or less on the Montreal Cognitive Assessment)
- Participation in a structured regular exercise program within the past 6 months
- Actively attempting to increase or decrease body mass
- Body mass index (BMI) of ≥ 35 kg/m2
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Post-exercise protein
Consumed 40 g of supplemental protein immediately after exercise sessions and in between breakfast and lunch on non-exercise days.
|
Post-exercise protein group consumed protein immediately after exercise sessions. Pre-sleep protein group consumed protein 30 minutes before sleep. |
Experimental: Pre-sleep protein
Consumed 40 g of supplemental protein 30 minutes before sleep every day.
|
Post-exercise protein group consumed protein immediately after exercise sessions. Pre-sleep protein group consumed protein 30 minutes before sleep. |
Placebo Comparator: Resistance exercise training only
Did not consume supplemental protein.
|
Resistance exercise training only group did not consume supplemental protein.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Muscle thickness
Time Frame: Week 0, 6, and 12
|
Change in muscle thickness of the quadriceps muscles in centimeters from week 0 (baseline) to week 6 (midpoint) to week 12 (end of study).
|
Week 0, 6, and 12
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Maximum muscular strength
Time Frame: Week 0, 6, and 12
|
Changes in strength of the chest press and leg press exercises in kilograms from week 0 (baseline) to week 6 (midpoint) to week 12 (end of study).
|
Week 0, 6, and 12
|
Muscle power
Time Frame: Week 0, 6, and 12
|
Changes in power (Watts) during a sit-to-stand task from week 0 (baseline) to week 6 (midpoint) to week 12 (end of study).
|
Week 0, 6, and 12
|
Cognitive performance
Time Frame: Week 0 and 12
|
Changes in the number of correct responses during the digit symbol substitution task and pattern comparison tests from week 0 (baseline) to week 12 (end of study).
|
Week 0 and 12
|
Measures associated appetite
Time Frame: Week 0, 6, and 12
|
Changes in subjective measures of hunger, satiety, and desire to eat on a 0-100 millimeter (higher values indicating stronger feeling) visual analog scale from week 0 (baseline) to week 6 (midpoint) to week 12 (end of study).
|
Week 0, 6, and 12
|
Total sleep time
Time Frame: Week 0 and 12
|
Changes in actigraphy watch measured total sleep time in hours from week 0 (baseline) to week 12 (end of study).
|
Week 0 and 12
|
Sleep latency
Time Frame: Week 0 and 12
|
Changes in actigraphy watch measured sleep latency in minutes from week 0 (baseline) to week 12 (end of study).
|
Week 0 and 12
|
Measures associated with sleep
Time Frame: Week 0 and 12
|
Changes in actigraphy watch measured sleep efficiency (ratio of time spent asleep to the time spent in bed) in percentage from week 0 (baseline) to week 12 (end of study).
|
Week 0 and 12
|
Nitrogen balance
Time Frame: Week 0 and 12
|
Changes in urinary nitrogen balance (grams per day) from week 0 (baseline) to week 12 (end of study).
|
Week 0 and 12
|
Free insulin-like growth factor 1
Time Frame: Week 0 and 12
|
Changes in plasma free insulin-like growth factor 1 concentration (nanogram per deciliter) from week 0 (baseline) to week 12 (end of study).
|
Week 0 and 12
|
Mood
Time Frame: Week 0 and 12
|
Changes in the Profile of Mood State rating scale categories of tension, depression, anger, fatigue, confusion, vigor, and total mood disturbance from week 0 (baseline) to week 12 (end of study) via a 1 to 5 scale (higher score indicates stronger feeling).
|
Week 0 and 12
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Alex O Klemp, PhD, Student
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 25996
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aging
-
Tuba MadenCompletedAging | Aging Problems | Aging Disorder
-
Radboud University Medical CenterNot yet recruitingAging | Aging Well | Immuno Aging
-
University of Santiago de CompostelaEuropean Regional Development Fund; Center for Industrial Technological Development...Completed
-
TruDiagnosticBlushield USANot yet recruitingAging | Aging Well
-
San Diego State UniversityCompleted
-
Lithuanian Sports UniversityCompletedAging | Healthy AgingLithuania
-
University of West AtticaNot yet recruiting
-
University of Santiago de CompostelaAgencia Estatal de Investigación, SpainRecruiting
-
Beijing HospitalBGI-ShenzhenCompletedAging | Healthy Aging
-
Amazentis SAproDERM GmbHCompleted
Clinical Trials on Protein
-
Örebro University, SwedenRecruitingIleostomy - StomaSweden
-
University of Illinois at Urbana-ChampaignNational Cattlemen's Beef AssociationRecruitingDietary Habits | Muscle Protein Synthesis | Meal FrequencyUnited States
-
National and Kapodistrian University of AthensHarokopio UniversityRecruitingType2 Diabetes MellitusGreece
-
McMaster UniversityCompleted
-
USDA Grand Forks Human Nutrition Research CenterActive, not recruitingObesityUnited States
-
FrieslandCampinaWageningen University and ResearchCompletedAmino Acid Plasma ProfileNetherlands
-
University of California, Los AngelesNational Institutes of Health (NIH)Completed
-
Purdue UniversityCompletedBlood Pressure | Cardiovascular Risk FactorUnited States
-
Concordia University, MontrealActive, not recruitingObesity | Obesity; EndocrineCanada